Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 4 Open-market buy Director bought 26,315 shares at $19.00 ($499,985)
  2. 4 Grant or award Co-Chief Executive Officer acquired 75,000 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Commercial Officer bought 6,842 shares at $19.00 ($129,998)
  5. 4 Grant or award Chief Financial Officer acquired 31,667 shares (grant or award)
  6. 4 Grant or award Co-Chief Executive Officer acquired 75,000 shares (grant or award)
  7. 424B4 Offering Prospectus
  8. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  9. EFFECT Other Notice of Effectiveness
  10. S-1MEF Other S-1MEF
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. CERT Other Certification

Page 21 of 23 · 446 filings